Google Chrome
Safari
Firefox
Edge
Press Release / Jan 17, 2023
Hovione is recognized as a Top Employer 2023
This certification is a recognition of Hovione´s resolve to put people first, and a validation that the investment in HR excellence is delivering.
Search
News / Jan 19, 2024
Hovione Macau awarded by the Government of Macau at a Ceremony held in Macau
Exciting News Alert from Hovione in Macau
Press Clipping / Jun 21, 2021
Hovione meets increased demand during Covid
Irish Examiner, 21 june 2021
Press Release / Jan 16, 2025
Hovione strengthens its global position as a top employer for the third consecutive year
Hovione has once again solidified its position as a top employer.
Press Release / Aug 23, 2022
Zerion Pharma and Hovione extend partnership to cover use of the Dispersome® technology platform in nutraceuticals
Hovione today announced an extension of collaboration on Zerion’s Dispersome® technology into the nutraceutical/dietary supplements field.
Press Release / Mar 17, 2021
Hovione completes its Phase 2 clinical trial of the first minocycline ophthalmic
Showing promise in Dry Eye Disease associated with Inflamed Meibomian Gland Dysfunction
Press Release / Dec 22, 2023
Hovione awarded prestigious industry medal by Macau Government
Hovione was recently awarded the Medal for Industrial and Commercial Merit by the Macau Government. Hovione started its manufacturing operations in Macau in 1986, producing lifesaving off-patent pharmaceutical actives for the world.
Press Release / Sep 19, 2024
Hovione and iBET Announce the Establishment of ViSync® Technologies: A Venture in Cell and Gene Therapy Solutions
Commitment to partnership and joint innovation for cell and gene therapies